Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). (2023). Eurasian Journal of Research, Development and Innovation, 26, 1-4. https://geniusjournals.org/index.php/ejrdi/article/view/5178